CAIO REBOUCAS FONSECA CAFEZEIRO
Projetos de Pesquisa
Unidades Organizacionais
3 resultados
Resultados de Busca
Agora exibindo 1 - 3 de 3
conferenceObject Coronary flow reserve by PET 13N-ammonia in patients with hereditary transthyretin amyloidosis with and without cardiac involvement(2022) ALENCAR NETO, A. C.; CAFEZEIRO, C. R. F.; BUENO, B. V. K.; SOUZA, F. Ribeiro De; RISSATO, J. H. S. Henrique; BORGES, T. Souza; CARVALHAL, S. Freitas; LIMA, M. Santos; BUCHPIGUEL, C. Alberto; CHALELA, W. Azem; RAMIRES, F. J. Alvarez; SZOR, R. Shcolnik; KALIL FILHO, R.; ROCHITTE, C. E.; FERNANDES, F.conferenceObject Non-invasive assessment of myocardial stiffness by the two-dimensional shear wave elastography ultrasound technique in patients with amyloidosis and Fabry disease(2023) CAFEZEIRO, C.; NETO, A. C. Alencar; BUENO, B. V. K.; RISSATO, J. H.; PEREIRA, N. M.; PEREIRA, F. L.; RAMIRES, F. J. A.; MATHIAS JR., W.; ROCHITTE, C. E.; HOTTA, V. T.; DABARIAN, A. L.; FERNANDES, F.- Cardiologic Manifestation in Amyloidosis(2023) ALENCAR NETO, A. C. de; CAFEZEIRO, C. R. F.; BUENO, B. V. K.; SINGULANE, C. de Carvalho; FERNANDES, F.ATTR and AL amyloidosis are responsible for approximately 95% of all cases of CA. Cardiac amyloidosis (CA) is a relatively common cause of heart failure with preserved ejection fraction (HFpEF). It is important to know that extracardiac changes may precede cardiac involvement by a few years; thus, it is essential to recognize these findings as part of the clinical feature in a patient with amyloidosis. CA results from the progressive deposition of amyloid fibrils in the extracellular space. The involvement of amyloidosis includes mechanical and electrical manifestations. The most frequent CA clinical presentation is HFpEF with a restrictive pattern leading to diastolic dysfunction, followed by systolic dysfunction. Conduction disorders and arrhythmias are commonly associated. © The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2023.